Search Results

The iPlan Hip Templating system is indicated for the preoperative planning of orthopedic treatments. It is specially developed for the preparation and display of anatomical patient data that has been acquired using xray, CT or MR equipment.

iPlan Hip Templating creates treatment plans in conjunction with 2D / 3D implant models are provided by a separate database. Both 2D and 3D planning are supported, depending on the anatomical information available.

The treatment plan can either be saved or printed as required.

iPlan Hip Templating is a stand-alone system for preoperative orthopedic treatment planning which facilitates digital template planning for anatomical images. Once image scaling has been completed, using an object of known size that is positioned next to the anatomical area of interest during image acquisition, the surgeons can use a range of measurement tools in order to select the optimum implant for the patient. The software overlays 2D / 3D implant models onto the image data and displays the result. The measurement tools can also be used to display preplanned and current values where required.

The digital implant models are provided by a separate implant database. Both 2D implant contours and 3D implant models are available.

Treatment plans can be saved and printed out as required. The information stored in the treatment plan can be loaded to other BrainLAB applications and used to support image guided surgery in a VectorVision system, for example.

Here's an analysis of the provided text regarding the iPlan® Hip Templating device, focusing on acceptance criteria and the study proving its performance:

1. Table of Acceptance Criteria and Reported Device Performance

The provided document does not explicitly state specific acceptance criteria (e.g., target accuracy percentages, precision thresholds) or detailed reported device performance in a quantitative manner.

Instead, the document makes a general statement:

2. Sample Size Used for the Test Set and Data Provenance

The document does not provide any specific information regarding:

• The sample size used for any test set.
• The country of origin of the data.
• Whether the data was retrospective or prospective.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

The document does not provide any information regarding:

• The number of experts used to establish ground truth.
• The qualifications of those experts.

4. Adjudication Method for the Test Set

The document does not mention any adjudication method used for a test set.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

The document does not mention or describe a multi-reader multi-case (MRMC) comparative effectiveness study. Therefore, no effect size of human improvement with AI vs. without AI assistance can be determined from this text.

6. Standalone (Algorithm Only) Performance Study

The document mentions that "iPlan Hip Templating is a stand-alone system for preoperative orthopedic treatment planning," implying its intended use as an algorithm-only tool for planning. However, it does not describe a specific standalone performance study in terms of metrics. The phrase "The validation proves the safety and effectiveness of the system" is a general statement about the system as a whole, not a detailed report of standalone algorithmic performance.

7. Type of Ground Truth Used

The document does not specify the type of ground truth used for any validation or testing.

8. Sample Size for the Training Set

The document does not provide any information regarding the sample size for the training set.

9. How the Ground Truth for the Training Set Was Established

The document does not provide any information regarding how the ground truth for the training set was established.

Summary of Findings:

The provided document (K042543 510(k) Summary) is a high-level regulatory submission focusing on demonstrating substantial equivalence to a predicate device (iPlan!®2 K020631). It asserts that the validation process (per BrainLAB's procedures) proves the safety and effectiveness of the system. However, it lacks the detailed technical information and study results typically found in reports specifically designed to describe acceptance criteria and evidence of meeting them. This type of information is often contained in the full 510(k) submission, which is not fully provided here. The summary focuses on the intended use, device description, and the FDA's concurrence with substantial equivalence rather than granular performance metrics and study details.

Ask a specific question about this device

iPlan!'s indications for use is to prepare and present patient and image data based on CT, MR, X-ray (Fluoro), including - image preparation - - image fusion - image segmentation - where the result is used for the creation of treatment plans for Stereotactic Surgery: - Surgery Planning - BrainMAP - Functional Planning In addition iPlan!'s indications for use is to prepare and present patient and image data based on CT, MR, X-ray (Fluoro) including - image preparation - - image fusion - image segmentation - where the result is preplanned data to be used by other BrainLAB medical devices such as VectorVision (for performing the planned treatment) where these medical devices are used for: Image Guided Surgery BrainLAB's Image Guided Surgery system is intended to be an intraoperative image guided localization system to enable minimally invasive surgery where the image guided surgery system is indicated for any medical condition in which the use of stereotactic surgery may be considered to be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or verfebra, can be identified relative to a CT, X-ray or MR based model of the anatomy. Example procedures include but are not limited to: - Cranial procedures - -Spine procedures - -ENT procedures Additional Indications For Use: iPlan! FiberTracking's indication for use is to prepare and present patient and image data based on MRI scanned with diffusion-weighted sequences. These diffusion images are used for the calculation and display of fiber bundles in a selected region of interest. The created treatment plans of iPlan! FiberTracking can be used with other iPlan! treatment plans and other BrainLAB medical devices such as VectorVision, where this medical device is used for image guided surgery.

iPlan! FiberTracking is developed to enhance functionality of iPlan! Cranial software with the import and planning of diffusion tensor images (DTI). Additional to the basic functions of iPlan! (viewing, drawing, image fusion and planning) this application provides functions for the import and display MRI anisotropic data, image processing of the DTI data and the display of the calculated fiber tracts.

The provided 510(k) summary for iPlan! FiberTracking does not contain explicit acceptance criteria or a detailed study proving the device meets said criteria.

The document states:
"iPlan! has been verified and validated according to BrainLAB's procedures for product design and development. The validation proves the safety and effectiveness of the information provided by BrainLAB in this 510(k) application was found to be substantially equivalent with the predicate device iPlan! (K020631)."

This statement indicates that a validation process was undertaken, but it does not specify the acceptance criteria used for the validation or details of the study itself. Without this information, I cannot complete the requested tables and descriptions.

Therefore, the following information cannot be extracted from the provided text:

• Table of Acceptance Criteria and Reported Device Performance: This would require specific performance metrics and thresholds, which are not present.
• Sample size used for the test set and data provenance: No information on the dataset used for testing.
• Number of experts used to establish the ground truth for the test set and qualifications of those experts: Not specified.
• Adjudication method for the test set: Not mentioned.
• If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance: This is a software component of a planning system; such a study is not typically described in this context for this type of device, and no such study is mentioned.
• If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not specified.
• The type of ground truth used: Not specified.
• The sample size for the training set: Not mentioned.
• How the ground truth for the training set was established: Not mentioned.

Ask a specific question about this device

iPlan!FLOW's indications for use incorporate the indications for use of iPlan! and thus is to prepare and present patient related medical image data based on CT and/or MR including

• image preparation -
• image fusion -
• image segmentation -
  display of guideline-visualizations for planning the placement of intra-cranial catheters where the result is used for the creation of treatment plans for:
  Stereotactic Surgery:
  The Surgery Planning is a tool for pre- and intraoperative stereotactic surgery planning based on stereotactic systems. Multiple graphical display functions and 3-dimensional views of anatomical structures offer effective and efficient means of presenting the anatomical data for diagnostic and surgical planning. Computer-graphic simulation in various views of a chosen probe path can help prevent probe intersections with unwanted, critical structures or vessels.
  The surgeon can interactively change a probe path simulation through the image slices in the software with on-line calculation of the accompanying arc settings and graphical manipulation to aid in optimizing his approach.
  In addition iPlan!FLOW's indications for use is to prepare and present patient and image data based on CT, MR, X-ray(Fluoro), Angiographic and other imaging sources including
• image preparation -
• image fusion -
• image segmentation -
  where the result is preplanned data to be used by other BrainLAB medical devices such as VectorVision (for performing the planned treatment) or where these medical devices are used for:
  Image Guided Surgery:
  BrainLAB's Image Guided Surgery system is intended to be an intraoperative image guided localization system to enable minimally invasive surgery where the image guided surgery system is indicated for any medical condition in which the use of stereotactic surgery may be considered to be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT or MR based model of the anatomy.
  The surgeon can interactively change a probe path simulation through the image slices in the software and graphical manipulate trajectories to optimize his approach. An intra-cranial catheter can be chosen and the path of the catheter can be planned. The user is provided with information by various displays and reconstruction planes based on patient images (CT, MRI, PET, SPECT) about the position and orientation relative to the patient of this catheter on brain structures or to a preplanned trajectory .
  iPlan!Flow can visualize guidelines for better placement of intra-cranial catheters. These guidelines comprise the minimal depth of the catheter tip in the brain tissue, the minimal distance of the catheter tip from intra-cranial surfaces and the minimal distance between different catheter tips. This visualization enables the surgeon to better plan and place intra-cranial catheters.
  iPlan!FLOW is designed as a planning system for pre- and intraoperative planning of stereotactic or image guided surgery treatments. It is specially designed to display anatomical images of a patient acquired with MR and/or CT as well as images derived from DTI-data acquired with Magnetic Resonance Imaging (MRI). iPlan!FLOW has a dedicated tool for planning trajectories of intra-cranial catheters. Guidelines for the catheter placement from the catheter supplier can be visualized and displayed to support the surgeon in improving catheter placement planning. iPlan!FLOW does not generate or create rules for the placement of intracranial catheters by any means. The Primary mode of action for iPlan!Flow is a device for creating treatment plans for stereotactic or image guided surqical treatment.
  The treatment plans can be used in conjunction with other BrainLAB medical devices such as VectorVision for image guided surgical treatment.

Like iPlan!® (K020631), iPlan!FLOW is a software tool running on a standard, stand-alone computer (PC or Laptop) or being accessible via the intranet connection for pre- or intraoperative planning of treatments based on stereotactic systems or image guided surgery systems.
Unchanged to iPlan!® (K020631) iPlan!FLOW provides e.g. tools for the automatic or manual segmentation of anatomical structures which enables the user such as radiologists or neurosurgeons to quickly achieve the desired segmentation results through an unlimited number of automatic and/or manual re-segmentations. Additionally to the predicate device iPlan! functional data derived from the Diffusion Tensor acquired by Magnetic Resonance Imaging (MRI) like maps of the fractional anisotropy (FA-Maps) and maps of the apparent diffusion coefficient (ADC-Trace-Map) can be displayed and matched with the anatomical data.
In addition to the trajectory-planning capabilities of iPlan!, iPlan!FLOW can be used for the planning of intracranial catheters, with image guided surgery. Guidelines provided by the catheter supplier for the exact placements of intracranial catheters can be visualized. These guidelines comprise the minimal depth of the catheter tip in the brain tissue, the minimal distance of the catheter tip from intra-cranial surfaces and the minimal distance between different catheter tips. This visualization enables the surgeon to better plan and place intra-cranial catheters.
The created treatment plans of iPlan!FLOW can be used on its own or in conjunction with other BrainLAB medical devices such as VectorVision for performing the planned treatment.

The provided text does not contain specific acceptance criteria or a detailed study proving the device meets said criteria in the format typically found in clinical trial reports or validation studies. Instead, it is a 510(k) summary for a medical device (iPlan!FLOW), which focuses primarily on establishing substantial equivalence to a predicate device.

However, based on the information provided, we can infer some aspects related to validation and equivalence.

Here's a breakdown of the requested information, addressing what is present and what is not:

1. Table of Acceptance Criteria and Reported Device Performance

This information is not explicitly provided in the document. The 510(k) summary states that "iPlan!FLOW has been verified and validated according to BrainLAB's procedures for product design and development. The validation proves the safety and effectiveness of the system." However, it does not specify the quantitative acceptance criteria (e.g., accuracy, precision thresholds) or detailed reported performance metrics for these criteria.

2. Sample size used for the test set and the data provenance

This information is not explicitly provided in the document. The text does not describe a specific test set, its sample size, or the provenance of the data used for validation.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

This information is not explicitly provided in the document. While it mentions that "radiologists or neurosurgeons" would use the device, it doesn't detail their involvement in establishing ground truth for a test set used in the validation.

4. Adjudication method for the test set

This information is not explicitly provided in the document. Since a detailed test set and ground truth establishment method are not described, an adjudication method is also not mentioned.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

There is no mention of a multi-reader multi-case (MRMC) comparative effectiveness study being performed or any effect size related to human reader improvement with AI assistance. The device is a planning system, and its validation focuses on its ability to support planning, not directly on improving human reader diagnostic accuracy in a comparative study.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

The device, iPlan!FLOW, is described as a "software tool running on a standard, stand-alone computer," which implies its functionality is standalone in terms of computation. However, its stated purpose is to "prepare and present patient related medical image data" for use by a surgeon for planning. It is an aid to a human user, not an autonomous diagnostic or therapeutic algorithm. Therefore, a standalone "algorithm only without human-in-the-loop performance" study as typically understood for AI diagnostic tools would not be directly applicable in the same way. The validation would instead focus on the accuracy of its planning tools and visualizations. The document does not describe such a study.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

This information is not explicitly provided in the document. Given that the validation "proves the safety and effectiveness of the system," it likely involved comparing the device's outputs (e.g., planned trajectories, segmentations, visualizations) against established anatomical knowledge, surgical principles, or potentially phantom studies, but the specific type of ground truth is not detailed.

8. The sample size for the training set

This information is not explicitly provided in the document. The 510(k) summary does not describe the development or training of any machine learning components in a way that would require a "training set" in the context of AI development. It functions more as a sophisticated software tool for image processing and visualization.

9. How the ground truth for the training set was established

This information is not explicitly provided in the document, for the same reasons as #8.

Summary of Device Validation and Equivalence (based on the provided text):

The 510(k) summary establishes that iPlan!FLOW is substantially equivalent to its predicate device, iPlan!® (K020631). The basis for this claim is:

• Similar Indications for Use: iPlan!FLOW incorporates the indications of iPlan! for preparing and presenting patient medical image data for stereotactic surgery planning, including image preparation, fusion, and segmentation.
• Expanded Indications: iPlan!FLOW adds indications for preparing and presenting data from additional sources (X-ray, Angiographic) and supports preplanned data for other BrainLAB devices (e.g., VectorVision) for image-guided surgery. It also specifically adds capabilities for planning intracranial catheter trajectories with visualization of supplier guidelines.
• Similar Technology: Both are software tools running on standard computers for pre- or intraoperative planning.
• Added Features: iPlan!FLOW includes additional features like displaying functional data from Diffusion Tensor Imaging (DTI-MRI) (FA-Maps, ADC-Trace-Map) and specific tools for planning intracranial catheters.
• Internal Validation: "iPlan!FLOW has been verified and validated according to BrainLAB's procedures for product design and development. The validation proves the safety and effectiveness of the system." This suggests internal testing and adherence to quality systems, but specific details of these tests are not publicly disclosed in this summary.

In essence, the document presents a regulatory justification for market clearance based on substantial equivalence, rather than a detailed scientific study report with explicit acceptance criteria and performance data.

Ask a specific question about this device